Such in vivo pathologies can be elegantly modeled in vitro upon addition of EGF + TGF-β1 to malignant human epithelial cells to mimic the frequently observed TGF-β1 elevation in the tumor microenvironment and amplified EGFR signaling characteristic of late-stage cancers [32]. This evidence concerns the gene TGFB1 and neoplasm.